Amberstone Biosciences’ transformative immunotherapeutics eliminate the issues of dose toxicity interfering with drug efficacy by introducing a safer class of therapeutic agents. Traditional therapies can be extremely effective at destroying tumors. However, the high dosage required for efficacy often has devastating effects on surrounding tissues. Our technology (T-MATEs™) allows us to target only the tumor without damaging healthy tissues.
Focusing on generating innovative biological respondents with a unique mode of action coupled with conditionally activated characertistics, we handle high value disease targets with huge upside potential. Targets that can be otherwise intractable for traditionnal targeting approaches.